aTyr Pharma, Inc.
(NASDAQ: ATYR)
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
0.821 -
+0.147
(+21.81%)
Range
0.740 - 0.885
(19.59%)
Open
0.750
Previous Close
0.674
Bid Price
0.821
Bid Volume
75
Ask Price
0.830
Ask Volume
500
Volume
11,938,398
Value
7,149,952
Remark
-
Delayed prices. Updated at 30 Jan 2026 03:11.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
